Horan Securities’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-415
Closed -$32K 310
2023
Q2
$32K Buy
415
+2
+0.5% +$160 0.01% 276
2023
Q1
$34.3K Sell
413
-49
-11% -$4.06K 0.02% 252
2022
Q4
$39.7K Buy
462
+1
+0.2% +$79 0.02% 236
2022
Q3
$28K Buy
461
+316
+218% +$19.9K 0.02% 242
2022
Q2
$9K Buy
145
+50
+53% +$3.1K 0.01% 342
2022
Q1
$6K Hold
95
﹤0.01% 365
2021
Q4
$7K Buy
+95
New +$6.54K ﹤0.01% 356
2021
Q2
$7K Hold
95
0.01% 334
2021
Q1
$6K Hold
95
0.01% 312
2020
Q4
$6K Sell
95
-25
-21% -$1.51K ﹤0.01% 294
2020
Q3
$8K Sell
120
-195
-62% -$13.5K 0.01% 224
2020
Q2
$24K Buy
315
+255
+425% +$19.5K 0.03% 111
2020
Q1
$4K Buy
+60
New +$4.15K 0.01% 183
2019
Q3
Sell
-87
Closed -$6K 265
2019
Q2
$6K Buy
+87
New +$5.72K 0.01% 207
2017
Q2
Sell
-209
Closed -$14K 181
2017
Q1
$14K Buy
+209
New +$14.7K 0.02% 79
2016
Q4
Sell
-206
Closed -$15K 73
2016
Q3
$15K Buy
+206
New +$16.7K 0.02% 70

Other funds holding GILD

Horan Securities's GILD Position: Q3 2023 in Review

Horan Securities sold out of Gilead Sciences (GILD) in Q3 2023, closing a stake of 415 shares — an estimated $32K sold.

Horan Securities first reported a position in GILD in Q3 2016 and held it in 16 quarters. The position peaked at $39.7K in Q4 2022. 1,683 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

  • Horan Securities reported no remaining Gilead Sciences position as of Q3 2023 after selling out during the quarter.
  • Horan Securities sold 415 Gilead Sciences shares in Q3 2023, an estimated $32K.
  • Horan Securities first reported a position in Gilead Sciences in Q3 2016 and held it in 16 quarters.
  • Horan Securities's Gilead Sciences position peaked at $39.7K in Q4 2022.
  • 1,683 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on Horan Securities's 13F filing for Q3 2023, filed 1 Nov 2023.